Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study
Neal D. Shore(Carolina Urologic Research Center), Simon Chowdhury(St Thomas' Hospital), Arnauld Villers(Université de Lille), Laurence Klotz(Sunnybrook Health Science Centre), D. Robert Siemens(Queen's University), De Phung(Astellas Pharma (Netherlands)), Steve van Os(Astellas Pharma (Netherlands)), Nahla Hasabou(Astellas Pharma (United States)), Fong Wang, Suman Bhattacharya, Axel Heidenreich(RWTH Aachen University)
Cited by 283
Abstract
Related Papers
No related papers found
Powered by citation graph analysis